Effect of Verdiperstat on Microglial Activation in Well-characterized MSA Patients

Clinical trial NCT04616456 · COMPLETED

Trial details

NCT number: NCT04616456
Sponsor: Brigham and Women's Hospital
Status: COMPLETED
Phase: Early Phase 1
Study type: INTERVENTIONAL

Multiple System Atrophy Multiple System Atrophy, Cerebellar Variant Multiple System Atrophy, Parkinson Variant (Disorder)Multiple System Atrophy (MSA) With Orthostatic Hypotension

Start date: 2020-12-30
Primary completion: 2022-01-30
Enrollment: 19

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.